GS MZ1 12.5 (Promacta 12.5 mg)
Generic Name: eltrombopag
Pill imprint GS MZ1 12.5 has been identified as Promacta 12.5 mg.
Promacta is used in the treatment of aplastic anemia; idiopathic thrombocytopenic purpura; thrombocytopenia idiopathic; thrombocytopenia and belongs to the drug class platelet-stimulating agents. Risk cannot be ruled out during pregnancy. Promacta 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Promacta (eltrombopag)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: platelet-stimulating agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.